Medical Devices Startups

Tetsuyu Healthcare provides CARES, a care management platform designed for social service organizations and healthcare providers. The platform supports care coordination and management operations.

1 investor

Texray develops woven, breathable radiation-protective textiles for medical professionals performing x-ray-guided interventions. The company's patented technology aims to reduce occupational radiation exposure in operating rooms.

1 investor

TFP Fertility Group is an international network of fertility clinics providing personalized reproductive treatment across the UK and Poland with satellite locations. The company combines 40+ years of clinical expertise in fertility care with a patient-centric approach to guide individuals through treatment journeys.

1 investor

TG Therapeutics is a biopharmaceutical company focused on developing treatments for cancer patients. The company is committed to patient care and is guided by a board with extensive expertise in biotechnology, pharmaceutical development, financial management, and medical oncology.

1 investor

Thabor Therapeutics is an INSERM spin-off developing a first-in-class therapeutic antibody targeting AGR2 for treating inflammatory mucosal diseases. The company focuses on immunology and therapeutic antibody development.

1 investor

The Blue Box is a diagnostic device that uses a urine reader with an electronic nose and AI analysis to detect breast cancer biomarkers in women aged 20-49 who lack reliable screening methods. The company has validated its technology through pilots with over 450 patients across 7 hospitals.

1 investor

The Insides Company develops medical devices for chyme reinfusion therapy, aimed at patients recovering from severe intestinal conditions such as inflammatory bowel disease, colorectal cancer, and intestinal fistulas. The company targets clinical and hospital settings and operates in the medical device and nutrition therapy category.

1 investor

The Mole Clinic provides skin cancer detection services, including full-body skin checks and mole mapping for early identification of melanoma and non-melanoma skin cancers. The clinic serves patients in the UK seeking professional mole and skin evaluation.

1 investor

The Renal Project delivers dialysis treatment services in India, combining medical expertise with quality assurance standards and technology solutions tailored to kidney care. The company serves patients in hinterland regions of India with a focus on safe, cost-effective, and effective dialysis delivery.

1 investor

Ritedose is a contract development and manufacturing organization (CDMO) that produces generic and specialty medications using advanced data analysis and custom technology solutions. The company serves patients and pharmaceutical clients by manufacturing high-quality drugs in cGMP-compliant facilities while maintaining a focus on safety, quality, and environmental sustainability.

1 investor

The Siesta Group provides computer-assisted sleep scoring and EEG biomarker extraction services, with AI-powered analysis of biometric signals for pharmaceutical and biotechnology firms. The company supports clinical trials focused on neurology therapies through centralized scoring and proprietary biomarker research tools.

1 investor

Develops a lollipop-shaped medical device for non-invasive collection of saliva samples used in the diagnosis and monitoring of various conditions. The device stimulates saliva production, filters and reduces sample viscosity, and delivers a laboratory-ready sample for healthcare professionals.

1 investor

Eva is an AI-powered research platform that conducts and maintains systematic reviews and meta-analyses by continuously updating them as new clinical trials emerge. It deploys AI research assistants to work alongside human expert reviewers to deliver initial analyses within 48 hours and keep findings current.

1 investor

Trendlines Group is an Israeli public company listed on Singapore Exchange that invests in and supports portfolio companies. The company operates through a board-driven governance structure serving shareholders and stakeholders.

1 investor

Ametris provides wearable digital health technology devices and remote monitoring platforms for clinical trials and pharmaceutical research. The company combines FDA-cleared medical-grade wearables, data processing algorithms, and operational support to help researchers capture real-world patient data across neurology, oncology, and other therapeutic areas.

1 investor

Daybreak provides at-home diagnosis and treatment for obstructive sleep apnea through doctor-directed virtual care and custom-tailored therapy. The company serves individuals with sleep apnea, offering an alternative to traditional in-office diagnosis and treatment managed by sleep medicine specialists.

1 investor

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

1 investor

LaunchPort is an investment and venture development organization focused on early-stage medical technology companies, with particular emphasis on medtech innovation and commercialization support.

1 investor

MRN operates a decentralized clinical trial site network that connects trial sponsors with diverse patient populations through flexible, community-based delivery models. The platform provides participating sites with eClinical technology, staffing support, and project management to enable faster patient recruitment and retention across traditional, hybrid, and remote trial settings.

1 investor

BraceX develops a portable device enabling patients to perform eccentric strengthening exercises safely at home, addressing rehabilitation accessibility barriers for orthopedic injuries and conditions like COPD and Parkinson's Disease.

1 investor

A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics. The company is currently operating in stealth mode.

1 investor

Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.

1 investor

TheraDep develops nanoscale plasma coating technology that bonds pharmaceuticals, biologics, and polymers onto surfaces such as metals, plastics, ceramics, and composites at room temperature. Its process targets manufacturers in the labware and medical device markets, offering custom coating solutions that integrate into existing production lines.

1 investor

ActaStim offers an FDA-approved electrical bone growth stimulation device used as an adjunct to lumbar spinal fusion surgery to improve fusion success and reduce failure rates. It is a medical device in the orthopedic/spine care category.

1 investor